CanaQuest Medical Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CANQF research report →
Price Chart
About the company
CanaQuest Medical Corp. focuses on creating health-related products and pharmaceutical solutions by leveraging the properties of hemp, cannabis, and algae oils. The company, which was originally established in 2008, previously operated under the name Algae Dynamics Corp.
- CEO
- Paul Ramsay
- IPO
- 2015
- Employees
- 10
- HQ
- Mississauga, ON, CA
Get TickerSpark's AI analysis on CANQF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.12K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.07
- P/B
- -0.00
- EV/EBITDA
- -0.29
- Div Yield
- 0.00%
- Gross Margin
- 39.85%
- Op Margin
- -4027.17%
- Net Margin
- -4093.13%
- ROE
- 131.32%
- ROIC
- 186.55%
Latest fiscal year · YoY change
- Revenue
- $45.95K+0.0%
- Gross Profit
- $18.31K+351.5%
- Op Income
- $-1,850,283
- Net Income
- $-1,880,589-67.0%
- EPS
- $-0.09-62.6%
- OCF Growth
- +43.8%
- FCF Growth
- +44.2%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.45
- RSI (14)
- 52
- Avg Volume
- 340.48K
No earnings-call transcripts are available for CANQF yet.
- Free Float
- 43.8%
- Shares Outstanding
- 21.21M
- Float Shares
- 9.28M
Our CANQF coverage
Recent articles, reports, and earnings notes.
No research on CANQF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CANQF report →CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
accesswire.com · Jul 26
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
accesswire.com · Apr 29
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
accesswire.com · Apr 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.